ArticleNPJ digital medicine2025
Equity-enhanced glaucoma progression prediction from OCT with knowledge distillation.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sparse-Observation Multi-Horizon Glaucoma Progression Forecasting with Biologically Constrained Temporal Consistency: A Glaucoma Case Study.Research square · 2026Article
- Clinical application of automated optical coherence tomography angiography for retinal fluid segmentation: a study of real-world data.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glaucoma is a progressive disease that can lead to permanent vision loss, making progression prediction vital for guiding effective treatment. Deep learning aids progression prediction but may yield unequal outcomes across demographic groups. We proposed a model called FairDist, which utilized baseline optical coherence tomography scans to predict glaucoma progression. An equity-aware EfficientNet was trained for glaucoma detection, which was then adapted for progression prediction with knowledge distillation. Model accuracy was measured by the AUC, Sensitivity, Specificity, and equity was assessed using equity-scaled AUC, which adjusts AUC by accounting for subgroup disparities. The mean deviation, fast progression, and total deviation pointwise progression were explored in this work. For both progression types, FairDist achieved the highest AUC and equity-scaled AUC for gender and racial groups, compared to methods with and without unfairness mitigation strategies. FairDist can be generalized to other disease progression prediction tasks to potentially achieve improved performance and fairness.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.